Navigation Links
Research Shows that Medical Students May Have a Hidden Obesity Bias, Suggesting Weight Loss via Supplements Like Liproxenol Could Inadvertently Enhance Medical Treatment
Date:6/18/2013

Australia (PRWEB) June 18, 2013

Several studies have been conducted regarding the bias that exists against people who are overweight. They’ve covered areas in the workforce as well as situations on a social level. However, a new study has found that medical students are likely to unknowingly have that same anti-obesity bias, suggesting that weight loss via supplements such as Liproxenol may inadvertently increase a person’s chances of proper medical care.

In a study published by Academic Medicine, the Journal of the Association of American Medical Colleges (AAMC), researchers looked at 354 medical students who were in their third year at Wake Forest School of Medicine. This next generation of doctors completed the Weight Implicit Association Test (IAT), which is a measure that reveals whether a person prefers individuals who are “fat” or “thin”.

In addition to the IAT, the students also answered a questionnaire about their known biases. Researchers then compared the results of the two to see how well the students recognized their own prejudices.

Of the 354 students, 310 agreed to take part in the study. Of those, 33% were found to have a self-recognized “moderate” or “strong” bias against obese individuals and none of them admitted to being biased against people who are thin.

However, the IAT test scores showed very different results. They discovered that 39% of the students were subconsciously anti-obese and 17% were anti-thin. This means that statistically, 67% of the participants were unaware of their bias.

This study suggests that future doctors need to become more aware of their bias so as not to unknowingly discriminate against their patients based on their weight. It also suggests that people who lose weight, via supplements such as Liproxenol, may inadvertently receive better medical care because of it.

Liproxenol is a weight loss supplement that contains all natural ingredients such as green tea, vitamin B6, cayenne powder and dandelion root. It was created by Liproxenol Nutraceuticals to increase metabolism, decrease appetite and burn excess fat.

About Liproxenol Nutraceuticals:
Liproxenol Nutraceuticals is recognized as an industry leader in the fields of health, wellness and better living. The company's products are enjoyed by customers around the world and are among a new class of supplements that are not only effective but also safe and made from 100% all-natural ingredients. Liproxenol Nutraceuticals is based in Australia and the USA.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10786296.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: